• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, September 13, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Opioid-related hospitalizations rising in Medicare patients without opioid prescriptions

Bioengineer by Bioengineer
April 17, 2018
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

GALVESTON, Texas – A 2014 federal change that limited the dispensing of hydrocodone products may be indirectly contributing to the illegal use of some of those drugs, a study by University of Texas Medical Branch researchers has found.

UTMB found that, while prescriptions for opioids went down among older Medicare recipients, opioid-related hospitalization of people who did not have a prescription for opioids went up.

In light of the growing opioid crisis, the Federal Drug Administration in October 2014 reclassified all hydrocodone products in a way that makes them more carefully controlled, including limiting prescriptions to a 30-day supply with no refills.

"Our team from The University of Texas Medical Branch at Galveston conducted the first study showing that the 2014 federal hydrocodone rescheduling policy was associated with decreased opiate use among the elderly," said Yong-Fang Kuo, professor in the department of preventive medicine and community health. "However, we also observed a 24 percent increase in opioid-related hospitalizations in Medicare patients without documented opioid prescriptions, which may represent an increase in illegal use."

Older adults are among the largest consumers of prescription opioids in the U.S. Compared with people holding commercial health insurance, Medicare enrollees are at least five times more likely to be diagnosed with opiate abuse and are also particularly vulnerable to toxic and other negative effects of opiate use.

The team also noted that they did not see decreased rates of opioid use among high-risk groups such as the disabled. Ten percent of the enrollees included in the analyses had initially become eligible for Medicare before age 65 because of disability. These people accounted for 25 percent of chronic opioid users and 40 percent of high-dose users in 2015.

"One explanation for the high rate of risky opioid use among disability-entitled enrollees is the group of risk factors linked with opioid misuse including mood disorders, cognitive disability and back pain-related disorders," Kuo said. "The continuing opioid epidemic despite state and federal actions highlights the need for people to continue supporting community-wide education on the risks and limitations of opioids, starting in medical and nursing schools, on safe opioid prescribing and how to recognize signs of opioid use disorder."

The UTMB research team conducted their analyses on a 20 percent national sample of Medicare enrollment and claims data from 2012 through 2015. The study is currently available in the new edition of the Journal of the American Geriatrics Society.

"As policy experts and medical professionals move forward in their search for the proper balance between pain control and opioid over-prescribing, it will be important to keep high-risk groups in mind when refining public policy and medical practice," said Kuo.

###

Other authors include UTMB's Mukaila Raji, Victor Liaw, Jacques Baillargeon and James Goodwin. The research was supported by the National Institutes of Health and the Agency for Healthcare Research and Quality.

Media Contact

Donna Ramirez
[email protected]
409-772-8791
@utmb_news

http://www.utmb.edu

https://www.utmb.edu/newsroom/article11763.aspx

Share12Tweet7Share2ShareShareShare1

Related Posts

Adverse Events in Asian Adults on Brivaracetam

September 13, 2025

ARFID hos förskolebarn: En screeningsstudie

September 13, 2025

Insights on Menstrual Health in Eating Disorder Units

September 12, 2025

Nicotine Dependence Linked to Health Behaviors in Korean Smokers

September 12, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    153 shares
    Share 61 Tweet 38
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    116 shares
    Share 46 Tweet 29
  • Physicists Develop Visible Time Crystal for the First Time

    65 shares
    Share 26 Tweet 16
  • A Laser-Free Alternative to LASIK: Exploring New Vision Correction Methods

    49 shares
    Share 20 Tweet 12

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Adverse Events in Asian Adults on Brivaracetam

Tumor Microenvironment Dynamics in Breast Cancer Therapy

Extraction Methods Impact Idesia Polycarpa Oil Quality

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.